Cargando…

A Systems Analysis Approach to Define the Protective Host Immune Responses of Children with Mild Respiratory Syncytial Virus Infection

BACKGROUND: Almost all children are infected with RSV by 2 yrs of age, yet <3% are hospitalized. The immune response of children with mild RSV infection who do not develop severe disease is not fully understood. Characterization of such response may have implications for vaccine development. We s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinonen, Santtu, Velazquez, Victoria M, Ye, Fang, Cohen, Daniel M, Mertz, Sara, Smith, Bennett, Garcia-Maurino, Cristina, Ramilo, Octavio, Mejias, Asuncion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631584/ http://dx.doi.org/10.1093/ofid/ofx163.1862

Ejemplares similares

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
por: Garcia-Mauriño, Cristina, et al.
Publicado: (2019)

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)

1465. Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
por: Brenes-Chacon, Helena, et al.
Publicado: (2020)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)

Respiratory Syncytial Virus bronchiolitis: Impact of second-hand smoke exposure on immune profiles
por: Diaz, Alejandro, et al.
Publicado: (2017)

118. Nasopharyngeal (NP) Bacterial Detection in Infants With Respiratory Syncytial Virus (RSV) Infection: Impact on Clinical Outcomes
por: Diaz, Alejandro, et al.
Publicado: (2018)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines
por: King, Tiffany, et al.
Publicado: (2021)

1186. Increased Respiratory Syncytial Virus (RSV) Viral Replication Leads to Increased Cytokine Production and Polarized Interferon Response in Infant Mucosal Epithelium
por: Glowinski, Rebecca M, et al.
Publicado: (2021)

Age and respiratory syncytial virus etiology in bronchiolitis clinical outcomes
por: Rodriguez-Fernandez, Rosa, et al.
Publicado: (2022)

2352. Increased on Childhood Recurrent Wheezing and Asthma After Respiratory Syncytial Viral (RSV) Infection in Full-Term Infants
por: Mejias, Asuncion, et al.
Publicado: (2018)

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: An experimental murine model
por: Chávez-Bueno, Susana, et al.
Publicado: (2005)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007)

Respiratory Syncytial Virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice
por: Torres, Juan Pablo, et al.
Publicado: (2010)

Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations
por: Nouri, Nima, et al.
Publicado: (2023)

79. Children with COVID-19 Demonstrate Distinct Serum Cytokines Profiles According to Clinical Presentations
por: Xu, Zhaohui, et al.
Publicado: (2021)

Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection
por: Mejias, Asuncion, et al.
Publicado: (2013)

Definition of erythroid cell‐positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection
por: Rinchai, Darawan, et al.
Publicado: (2020)

Superiority of Transcriptional Profiling Over Procalcitonin for Distinguishing Bacterial From Viral Lower Respiratory Tract Infections in Hospitalized Adults
por: Suarez, Nicolas M., et al.
Publicado: (2015)

The importance of viral testing in infants and young children with bronchiolitis()
por: Mejias, Asuncion, et al.
Publicado: (2022)

Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia
por: Wallihan, Rebecca G., et al.
Publicado: (2018)

Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)

204. Mucosal Cytokine Profiles in Children with COVID-19
por: Cohen, Shira H, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19
por: Bline, Katherine, et al.
Publicado: (2022)

Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19
por: Quintero, Ana M, et al.
Publicado: (2022)

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019)

Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus
por: Feng, Ziheng, et al.
Publicado: (2022)

118 Transcriptional Profiling Discriminates Complete and Incomplete Kawasaki Disease (KD) from Adenovirus infection (HAdV)
por: Jaggi, Preeti, et al.
Publicado: (2014)

Viral Loads and Disease Severity in Children with Rhinovirus-Associated Illnesses
por: Sanchez-Codez, Maria I., et al.
Publicado: (2021)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
por: Terletskaia-Ladwig, Elena, et al.
Publicado: (2005)

An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Zuniga, Armando, et al.
Publicado: (2021)

Host cytoskeleton in respiratory syncytial virus assembly and budding
por: Shahriari, Shadi, et al.
Publicado: (2016)

Host and Viral Factors in Respiratory Syncytial Virus Infection
por: Mastrangelo, Peter, et al.
Publicado: (2013)

Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era
por: Bernstein, David I, et al.
Publicado: (2022)

Overnutrition, Nasopharyngeal Pathogenic Bacteria and Proinflammatory Cytokines in Infants with Viral Lower Respiratory Tract Infections
por: Arias-Bravo, Guisselle, et al.
Publicado: (2022)

A novel host factor for human respiratory syncytial virus
por: Mehedi, Masfique, et al.
Publicado: (2017)

Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
por: Quintero, Ana Maria, et al.
Publicado: (2022)

2619. Clinical Characteristics and Etiology of Community-Acquired Pneumonia in Children: A Contemporary, Prospective, Multicenter Study in Ohio, 2015–2018
por: Yun, Ki Wook, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bk5r6idhg53jppaeqneicf75ko